Header cover image

U.S. Pharmaceuticals & Biotech Huge Earnings Growth

UPDATED Jun 29, 2024

Companies which grew earnings more than 50% in the last year.

40 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NBIX

Neurocrine Biosciences		US$137.672.3%46.0%US$13.9bUS$160.54PE37.5xE27.1%n/a

PBYI

Puma Biotechnology		US$3.269.0%-7.6%US$157.3mUS$4.33PE10.2xE-37.8%n/a

INCY

Incyte		US$60.62-4.1%-2.6%US$13.6bUS$72.80PE18.3xE17.3%n/a

ELTP

Elite Pharmaceuticals		US$0.2020.6%419.6%US$212.6mn/aPE13.7xn/an/a

BUDZ

WEED		US$0.0650.3%-26.7%US$8.2mn/aPB76.7xn/an/a

AMYT

Amryt Pharma		US$14.700.7%86.5%US$940.7mUS$20.75PS3.9xE53.9%n/a

ACAD

ACADIA Pharmaceuticals		US$16.256.2%-32.2%US$2.7bUS$27.35PS3.3xE41.5%n/a

ADMA

ADMA Biologics		US$11.181.6%203.0%US$2.6bUS$11.00PS9.2xE30.6%n/a

APRE

Aprea Therapeutics		US$4.071.5%29.2%US$22.1mUS$15.67PS22.9xE7.6%n/a

WINT

Windtree Therapeutics		US$3.212.2%-85.7%US$1.9mUS$18.00PB0.1xE-26.2%n/a

MJNE

MJ Holdings		US$0.0043-23.0%-72.9%US$252.3kn/aPB0.2xn/an/a

CBDL

CBD Life Sciences		US$0.0031-21.5%933.3%US$439.2kn/aPS2.5xn/an/a

BLUE

bluebird bio		US$0.989.5%-70.1%US$189.7mUS$3.79PS8.7xE14.9%n/a

ATAI

Atai Life Sciences		US$1.33-0.7%-22.7%US$222.7mUS$11.80PS803.8xE37.8%n/a

HALO

Halozyme Therapeutics		US$52.361.6%45.2%US$6.7bUS$57.40PE20.9xE21.7%n/a

MGNX

MacroGenics		US$4.25-2.7%-20.6%US$266.2mUS$10.80PS6.1xE-23.2%n/a

PKTX

ProtoKinetix		US$0.01-6.5%-58.9%US$3.5mn/aPB9xn/an/a

EMMA

Emmaus Life Sciences		US$0.1011.2%-56.0%US$6.5mn/aPE-1.4xn/an/a

TEVA

Teva Pharmaceutical Industries		US$16.25-4.2%115.8%US$18.4bUS$18.74PS1.2xE40.5%0%

ICPT

Intercept Pharmaceuticals		US$19.000.1%19.1%US$794.7mUS$19.00PS2.5xE42.4%n/a

APM

Aptorum Group		US$4.38-4.1%62.3%US$24.0mn/aPS55.6xn/an/a

YMAB

Y-mAbs Therapeutics		US$12.080.7%77.9%US$530.1mUS$21.29PS6.3xE-20.2%n/a

ACST

Acasti Pharma		US$2.92-11.5%-7.3%US$27.4mUS$5.98PB0.4xE-19.2%n/a

MTEM

Molecular Templates		US$1.155.5%-84.0%US$7.6mUS$18.00PB1.3xE-37.7%n/a
Page 1 of 2
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.